Skip to content

The genetic etiology of cannabis use: from twin models to genome-wide association studies and beyond

February 5, 2026 9:00 AM - 10:00 AM

Zoom (See email for Zoom link)

Panel

Karin Verweij | Brain and Behavior Research Foundation

Karin Verweij is Professor of Genetics in Psychiatry at Amsterdam UMC (Department of Psychiatry), University of Amsterdam. Her research focuses on the genetic and biological mechanisms underlying psychiatric disorders and human behavior. In particular, she studies substance use and addiction, and the relationship between substance use and psychiatric disorders.

Abstract

Cannabis use is one of the most widely used psychoactive drugs worldwide and shows substantial genetic influence. This talk provides an overview of the genetic studies of cannabis use, drawing on evidence from twin studies, early gene-finding efforts, and large-scale genome-wide association studies (GWAS) and secondary analyses of these GWAS results. Twin studies indicate moderate heritability, increasing with more severe use, while recent GWAS have identified multiple associated loci, including CADM2. I will present results from the latest, unpublished GWAS of cannabis use frequency, alongside updated analyses of lifetime use, including trans-ancestry findings. Multivariate and causal genetic analyses reveal substantial shared genetic liability with other substance use and psychiatric disorders.